{"id":"W2787457224","doi":"10.1158/1535-7163.targ-17-a082","title":"Abstract A082: A phase I study of the MDM2 antagonist RO6839921, a pegylated intravenous prodrug of idasanutlin, in patients with AML","year":2018,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Neutropenia; Nausea; Pharmacology; Prodrug; Dosing; Vomiting; Internal medicine; Pharmacodynamics; Phases of clinical research; Pharmacokinetics; Gastroenterology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001725172,0.0003178617,0.0005613699,0.0001718351,0.00006989541,0.0000138222,0.0002977284,0.0001435236,0.00005267478],"category_scores_gemma":[0.00001925464,0.0002269349,0.0001203251,0.0008940301,0.0003367736,0.00004035547,0.00007329696,0.0004254758,0.000002128859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002328893,"about_ca_system_score_gemma":0.000493613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006863455,"about_ca_topic_score_gemma":0.0005654203,"domain_scores_codex":[0.9976671,0.0001063777,0.000642345,0.000433329,0.000769496,0.0003813539],"domain_scores_gemma":[0.99797,0.00001634615,0.0004399998,0.0009330142,0.0005546472,0.00008596377],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01461505,0.02780105,0.1714508,0.0005410168,0.003379257,0.0002243951,0.02107435,0.0007326357,0.7067634,0.00004909507,0.00005388228,0.05331512],"study_design_scores_gemma":[0.04670158,0.0134714,0.3441768,0.001080018,0.001400244,0.00001437508,0.0009769175,0.0004354978,0.59015,0.00005142957,0.0009222493,0.0006195202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959949,0.0006965894,0.0001413753,0.0001570858,0.0001984487,0.002482628,0.00005707367,0.00003053403,0.000241426],"genre_scores_gemma":[0.9992591,0.00003578852,0.00009131483,0.0003843312,0.00004131103,0.00006808192,0.00001637067,0.0000871044,0.00001656712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.172726,"threshold_uncertainty_score":0.9254135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01546502045544257,"score_gpt":0.2865701823240733,"score_spread":0.2711051618686307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}